Sharon, MA, United States of America

Jeffrey Morgan

This inventor holds 1 USPTO granted patent. Top assignee: Magee-Womens Research Institute & Foundation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Morgan. Retrieved from https://idiyas.com/inventor/jeffrey-morgan-yixhakpo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeffrey Morgan: Innovator in Biofabrication

Introduction

Jeffrey Morgan is a notable inventor based in Sharon, MA (US). He has made significant contributions to the field of biofabrication, particularly in the development of living tissue grafts. His innovative work addresses critical challenges in tissue engineering and regenerative medicine.

Latest Patents

Morgan holds a patent for the "Biofabrication of vaginal support using vaginally derived cells." This invention relates to a living tissue graft derived from autologous cells, which is used to provide support or to strengthen and reinforce compromised tissue. The living tissue graft comprises both cells and extracellular matrix (ECM), effectively overcoming issues related to foreign body responses to synthetic materials and rejection reactions to allograft tissue. He has 1 patent to his name.

Career Highlights

Jeffrey Morgan is affiliated with the Magee-Womens Research Institute & Foundation, where he continues to advance research in biofabrication and tissue engineering. His work is pivotal in developing innovative solutions for women's health issues.

Collaborations

Morgan collaborates with esteemed colleagues, including Pamela A. Moalli and Vivian Sung, who contribute to his research endeavors and enhance the impact of his work.

Conclusion

Jeffrey Morgan's contributions to biofabrication and tissue engineering represent a significant advancement in medical technology. His innovative approach to creating living tissue grafts has the potential to improve patient outcomes and revolutionize treatment options in regenerative medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…